MindMed to Participate in March Investor Conferences
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) has announced its participation in three upcoming investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
-
Cowen 43rd Annual Healthcare Conference
- Format: Investor Presentation
-
Date and Time:
Wednesday, March 8, 2023 at1:30 pm EST -
Webcast Link:
Cowen Healthcare Conference
-
Oppenheimer 33rd Annual Healthcare Conference
- Format: Investor Presentation
-
Date and Time:
Monday, March 13, 2023 at2:00 pm EST - Webcast Link: Oppenheimer 33rd Annual Healthcare Conference
-
35th Annual
Roth Conference - Format: Fireside Chat
-
Date and Time:
Monday, March 13, 2023 at2:30 pm PST /5:30 pm EST -
Webcast Link: 35th Annual
Roth Conference
Audio webcasts and replays of these presentations will be available on MindMed’s Investor Resources website for up to 90 days following each event.
About MindMed
MindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health disorders.
MindMed trades on NASDAQ under the symbol MNMD and on the Canadian
View source version on businesswire.com: https://www.businesswire.com/news/home/20230228005602/en/
For Media & Investor Inquiries, please contact:
Vice President, Investor Relations and Corporate Communications
ir@mindmed.co
media@mindmed.co
Source: MindMed